Wellis Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: people who want one flat monthly price for compounded semaglutide or tirzepatide, charged only if prescribed
Wellis scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $199 a month; its compounded tirzepatide, at $249, is 7% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked November 2026
Wellis is an online clinic for weight loss, hair loss and erectile dysfunction, one of several brands on a telehealth network run by TagadaPay LLC of Houston. Clinicians from MDI Medical Group review an online questionnaire and may prescribe compounded semaglutide or tirzepatide. Plans are $199 a month for semaglutide and $249 for tirzepatide at every dose, with the consult and shipping included, and the card is charged only if a clinician prescribes.
Is Wellis legit?
Yes. Wellis is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Wellis promo or coupon code?
We know of no promo or coupon code for Wellis. Its listed price is $199 a month. Coupon sites advertising "Wellis discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Wellis compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Wellis
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Bodybuilding Health+
Best for: seeing what it charges before you answer any medical questions
Editorial score · methodology
Wellis at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How Wellis scores
Six columns, each one computed from something Wellis has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.6/10$249/month is 7% below the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Wellis
Last checked November 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Wellis
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Wellis involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Wellis shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Wellis which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $249. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Wellis serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Wellis
- Wellis offers email support
Cancelling Wellis
Taken from the terms Wellis publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None; monthly plans renew on or around each refill's ship date until canceled
- Refund policy
- Terms section 7: "If the reviewing provider declines to prescribe, the hold is released and you are not charged." "medication orders that have shipped are non-refundable, except where required by law." "Consultation fees are non-refundable once a provider has begun reviewing your case."
- Early-termination fee
- None
Medications Wellis lists
Wellis lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
FAQ: "Plans from $199/mo (compounded semaglutide) ... Includes clinician consultation and shipping. Same price at every dose." The live store record (Semaglutide Program) is $199.00 recurring every 1 month.
FAQ: "... or $249/mo (compounded tirzepatide), if prescribed." The live store record (Tirzepatide Program) is $249.00 recurring every 1 month.
Check the price yourself before you pay
Every figure here comes from Wellis's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $249 a month, 7% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Wellis
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Wellis charges
Wellis lists $199/month, flat regardless of dose. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $249/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Wellis' $249 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare Wellis' cancellation terms with other sellers' cancellation and refund policies.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What Wellis dispenses
Wellis prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
Wellis tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to Wellis. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Wellis will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Wellis bills your plan before you start.
It fits if
- you want the price to stop moving as your dose climbs
Our read
Wellis lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Belle Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Wellis scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on availability. It charges from $199 a month; its compounded tirzepatide, at $249, is 7% below the $269 median among the sellers we compare.
Before you pay Wellis
Starting at $199 a month. Check today's price, then start the intake.
Where Wellis is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Wellis sets more sellers in the same category beside Wellis on price, states and what the price includes.
Frequently Asked Questions
How to check Wellis yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Wellis review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Wellis's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.